$XWEL
XWELL Inc Stock $xwel

$xwel Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000114420413059609 Filed on November 07, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q4
Revenue	$0.00	$0.00	-$170.0K
YoY Change	-100.0%	-100.0%	-206.25%
Cost Of Revenue	$5.990M	$6.725M	$5.220M
YoY Change	14.75%	96.93%	10340.0%
Gross Profit	-$5.990M	-$6.725M	-$5.390M
YoY Change	11.13%	113.56%	-5000.0%
Gross Profit Margin
Selling, General & Admin	$3.880M	$3.801M	$2.720M
YoY Change	42.65%	-40.27%	140.71%
% of Gross Profit
Research & Development	$230.0K	$542.0K	-$450.0K
YoY Change	-151.11%	-45.64%	-180.36%
% of Gross Profit
Depreciation & Amortization		$860.0K
YoY Change		-28.93%
% of Gross Profit
Operating Expenses	$5.360M	$4.343M	$2.270M
YoY Change	136.12%	-41.0%	35.12%
Operating Profit	-$11.00M	-$10.52M	-$7.660M
YoY Change	43.66%	0.09%	387.9%
Interest Expense	$30.00K	$650.0K	-$390.0K
YoY Change	-107.69%	-91.02%	-69.29%
% of Operating Profit
Other Income/Expense, Net	$170.0K	$30.00K	-$2.950M
YoY Change	-105.76%	-57.14%	-9933.33%
Pretax Income	-$10.81M	-$9.849M	-$11.50M
YoY Change	-6.0%	207.78%	309.25%
Income Tax	$260.0K	$0.00	$130.0K
% Of Pretax Income
Net Earnings	-$18.97M	-$10.56M	-$14.01M
YoY Change	35.4%	238.03%	396.81%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.23	-$0.13
Diluted Earnings Per Share	-$0.23	-$0.13	-$93.40M
COMMON SHARES
Basic Shares Outstanding	84.13M shares	83.54M shares
Diluted Shares Outstanding		86.10M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.60M	$41.10M	$57.00M
YoY Change	-41.05%	332.63%	996.15%
Cash & Equivalents	$33.59M	$40.44M	$56.96M
Short-Term Investments		$700.0K
Other Short-Term Assets	$455.0K	$700.0K	$469.0K
YoY Change	-2.99%	16.67%
Inventory
Prepaid Expenses
Receivables		$98.00K	$151.0K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$34.83M	$41.86M	$57.43M
YoY Change	-39.35%	306.44%	3242.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$230.0K	$249.0K	$294.0K
YoY Change	-21.77%	-17.0%	104.17%
Goodwill	$67.76M	$65.97M	$65.97M
YoY Change	2.72%
Intangibles	$22.75M	$30.36M	$34.04M
YoY Change	-33.18%
Long-Term Investments
YoY Change
Other Assets	$247.0K	$0.00	$100.0K
YoY Change	147.0%	-100.0%
Total Long-Term Assets	$88.98M	$96.62M	$100.4M
YoY Change	-11.33%	-7.45%	56598.87%
TOTAL ASSETS
Total Short-Term Assets	$34.83M	$41.86M	$57.43M
Total Long-Term Assets	$88.98M	$96.62M	$100.4M
Total Assets	$123.8M	$138.5M	$157.8M
YoY Change	-21.53%	20.73%	8226.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.100M	$4.000M	$1.400M
YoY Change	264.29%	33.33%	250.0%
Accrued Expenses	$300.0K	$300.0K	$400.0K
YoY Change	-25.0%	-62.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$5.488M	$4.267M	$1.842M
YoY Change	197.94%	-5.18%	154.77%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$0.00	$4.100M	$7.600M
YoY Change	-100.0%	-76.3%
Total Long-Term Liabilities	$0.00	$4.100M	$7.600M
YoY Change	-100.0%	-76.3%	225.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.488M	$4.267M	$1.842M
Total Long-Term Liabilities	$0.00	$4.100M	$7.600M
Total Liabilities	$5.488M	$8.400M	$9.500M
YoY Change	-42.23%	-65.85%	210.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.03M
YoY Change
Common Stock	$845.0K	$841.0K	$819.0K
YoY Change	3.17%		719.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$114.3M	$130.1M	$148.3M
YoY Change
Total Liabilities & Shareholders Equity	$123.8M	$138.5M	$157.8M
YoY Change	-21.53%	20.73%	8226.44%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q4
OPERATING ACTIVITIES
Net Income	-$18.97M	-$10.56M	-$14.01M
YoY Change	35.4%	238.03%	396.81%
Depreciation, Depletion And Amortization		$860.0K
YoY Change		-28.93%
Cash From Operating Activities	-$6.090M	-$6.410M	-$8.510M
YoY Change	-28.44%	92.49%	559.69%
INVESTING ACTIVITIES
Capital Expenditures	-$1.410M	$0.00	-$60.00K
YoY Change	2250.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$480.0K	$2.440M	$0.00
YoY Change		-25.61%	-100.0%
Cash From Investing Activities	-$950.0K	$2.450M	-$60.00K
YoY Change	1483.33%	-112.62%	-400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	1.210M	55.97M
YoY Change	-99.96%	-95.93%	7075.64%
NET CHANGE
Cash From Operating Activities	-6.090M	-6.410M	-8.510M
Cash From Investing Activities	-950.0K	2.450M	-60.00K
Cash From Financing Activities	20.00K	1.210M	55.97M
Net Change In Cash	-7.020M	-2.750M	47.40M
YoY Change	-114.81%	-139.4%	-9773.47%
FREE CASH FLOW
Cash From Operating Activities	-$6.090M	-$6.410M	-$8.510M
Capital Expenditures	-$1.410M	$0.00	-$60.00K
Free Cash Flow	-$4.680M	-$6.410M	-$8.450M
YoY Change	-44.62%	-133.11%	555.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151000	USD
	dei	Trading Symbol TradingSymbol	VRNG
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84125738	shares
	dei	Entity Registrant Name EntityRegistrantName	Vringo Inc
	dei	Entity Central Index Key EntityCentralIndexKey	0001410428
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	33473000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	14481000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	61356000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11176000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10510000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-32197000	USD
CY2012Q3	us-gaap	Costs And Expenses CostsAndExpenses	10776000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	6000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1842000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4267000	USD
CY2012Q3	us-gaap	Revenues Revenues	266000	USD
CY2013Q3	us-gaap	Revenues Revenues	50000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98000	USD
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86101857	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58227100	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82972082	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35047440	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47800063	shares
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2858000	USD
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5362000	USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84120724	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81889226	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84120724	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81889226	shares
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	656000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	318000	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	3415000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	700000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-10560000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83538767	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48790819	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82882405	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25611159	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46339586	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8975000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5532000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17536000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2754000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	2865000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	76000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8087000	USD
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	54961000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2883000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
CY2012	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	22932000	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30360000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	34044000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	65965000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	65965000	USD
CY2013Q3	us-gaap	Assets Assets	138483000	USD
CY2012Q4	us-gaap	Assets Assets	157786000	USD
CY2013Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4011000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1444000	USD
CY2013Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	256000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	398000	USD
CY2013Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4126000	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7612000	USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40436000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56960000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	673000	USD
CY2012Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	41863000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	57429000	USD
CY2013Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	46000	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	54000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	294000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	841000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	819000	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	186308000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171108000	USD
CY2013Q3	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	57059000	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	23595000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	130090000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	148332000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138483000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157786000	USD
	us-gaap	Revenues Revenues	1276000	USD
	us-gaap	Revenues Revenues	266000	USD
	us-gaap	Revenues Revenues	1645000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	6725000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	19557000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	5976000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	33630000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	997000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2110000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	997000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3850000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3801000	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6364000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11806000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7508000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23876000	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	11226000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14215000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-59711000	USD
CY2013Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30000	USD
CY2012Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	82000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	76000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	82000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	114000	USD
CY2013Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	30000	USD
CY2012Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	12000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	76000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	19000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	104000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1220000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7240000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	5627000	USD
CY2013Q3	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	0	USD
CY2012Q3	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	0	USD
	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	0	USD
	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	0	USD
	vrng	Income Loss From Issuance Of Inducement Warrants IncomeLossFromIssuanceOfInducementWarrants	-2883000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10531000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-33417000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6912000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-56957000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-76000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-76000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	102000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-3124000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33464000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6836000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-57059000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2012Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7240000	USD
CY2013Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	645000	USD
CY2012	vrng	Adjustments To Additional Paid In Capital Net Fair Value Of Warrant Issued AdjustmentsToAdditionalPaidInCapitalNetFairValueOfWarrantIssued	21954000	USD
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	0	USD
	vrng	Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round One AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundOne	5145000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	474000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14076000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	509000	USD
CY2012	vrng	Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round One AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundOne	31148000	USD
CY2012	vrng	Stock Issued During Period For Patents StockIssuedDuringPeriodForPatents	750000	USD
CY2012	vrng	Adjustment To Additonal Paid In Capital Issuance Of Shares In Financing Round Two AdjustmentToAdditonalPaidInCapitalIssuanceOfSharesInFinancingRoundTwo	44962000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-20841000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	973000	USD
	vrng	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	1356000	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	3918000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3856000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1211000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6686000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-162000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-57000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8975000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5532000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17536000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2883000	USD
	vrng	Assignment Of Patents AssignmentOfPatents	100000	USD
	vrng	Assignment Of Patents AssignmentOfPatents	0	USD
	vrng	Assignment Of Patents AssignmentOfPatents	100000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-11000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-19000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	283000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	504000	USD
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	517000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2400000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2043000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2856000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17384000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5962000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33380000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	151000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	244000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	673000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	673000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22548000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25944000	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	-8000	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	46000	USD
	us-gaap	Payments For Deposits PaymentsForDeposits	38000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3326000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3326000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-692000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19419000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23573000	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	0	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	31148000	USD
	vrng	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	31148000	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	0	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	0	USD
	vrng	Proceeds From Issuance Of Common Stock Two ProceedsFromIssuanceOfCommonStockTwo	44962000	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-3200000	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	0	USD
	vrng	Proceeds From Mezzanine Preferred Stock ProceedsFromMezzaninePreferredStock	1800000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5145000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	973000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	171000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1482000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	201000	USD
	vrng	Noncash Or Part Noncash Acquisition Working Capital Acquired NoncashOrPartNoncashAcquisitionWorkingCapitalAcquired	740000	USD
	vrng	Noncash Or Part Noncash Acquisition Long Term Deposit Acquired NoncashOrPartNoncashAcquisitionLongTermDepositAcquired	-8000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	566000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1598000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12841000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1539000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29717000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97378000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	13000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	11000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16524000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4337000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	40436000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5212000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9549000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	9000	USD
	us-gaap	Interest Paid InterestPaid	17000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	22000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	32000	USD
	vrng	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	0	USD
	vrng	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	0	USD
	vrng	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	39000	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	790000	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	596000	USD
	vrng	Conversion Of Derivative Warrant ConversionOfDerivativeWarrant	11447000	USD
	vrng	Purchase Patents PurchasePatents	0	USD
	vrng	Purchase Patents PurchasePatents	0	USD
	vrng	Purchase Patents PurchasePatents	750000	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	0	USD
	vrng	Adjustments To Additional Paid In Capital Conversion Of Derivative Warrants Into Equity Warrants AdjustmentsToAdditionalPaidInCapitalConversionOfDerivativeWarrantsIntoEquityWarrants	3918000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	0	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	76000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Prior To Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPriorToMerger	76000	USD
	vrng	Conversion Of Preferred Stock Into Common Stock Upon Merger ConversionOfPreferredStockIntoCommonStockUponMerger	0	USD
	vrng	Conversion Of Preferred Stock Into Common Stock Upon Merger ConversionOfPreferredStockIntoCommonStockUponMerger	1724000	USD
	vrng	Conversion Of Preferred Stock Into Common Stock Upon Merger ConversionOfPreferredStockIntoCommonStockUponMerger	1724000	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	0	USD
	vrng	Conversion Of Series Convertible Preferred Stock Classified As Equity Into Common Stock Post Merger ConversionOfSeriesConvertiblePreferredStockClassifiedAsEquityIntoCommonStockPostMerger	201000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	124000	USD
	vrng	Noncash Or Part Noncash Acquisition Goodwill Acquired NoncashOrPartNoncashAcquisitionGoodwillAcquired	-65965000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	10133000	USD
	vrng	Noncash Or Part Noncash Acquisition Fair Value Of Common Stock Acquired NoncashOrPartNoncashAcquisitionFairValueOfCommonStockAcquired	58211000	USD
	vrng	Noncash Or Part Noncash Acquisition Fair Value Of Warrants Acquired NoncashOrPartNoncashAcquisitionFairValueOfWarrantsAcquired	17443000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	3162000	USD
	vrng	Total Cash Acquired During Acquisition TotalCashAcquiredDuringAcquisition	3326000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-60446000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt; COLOR: black"></font></b> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt; COLOR: black">Note 1. General</font><font style="FONT-SIZE: 10pt"></font></b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">  </font> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black"> Vringo, Inc., together with its consolidated subsidiaries (the “Company”), is engaged in the development and monetization of intellectual property worldwide. The Company's intellectual property portfolio consists of over 500 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally and acquired from third parties. The Company operates a global platform for the distribution of mobile social applications and services it develops.</font><font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">  </font> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">On July 19, 2012, Vringo, Inc., a Delaware corporation (“Vringo” or “Legal Parent”), closed a merger transaction (the “Merger”) with Innovate/Protect, Inc., a privately held Delaware corporation (“I/P”), pursuant to an Agreement and Plan of Merger, dated as of March 13, 2012 (the “Merger Agreement”), by and among Vringo, I/P and VIP Merger Sub, Inc., a wholly-owned subsidiary of Vringo (“Merger Sub”). Pursuant to the Merger Agreement, I/P became a wholly-owned subsidiary of Vringo through a merger of I/P with and into Merger Sub, and the former stockholders of I/P received shares of Vringo that constituted a majority of the outstanding shares of Vringo.</font><font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt; COLOR: black"> </font> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black"> Immediately following the Merger, approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 67.61</font>% of the combined company was owned by I/P stockholders on a fully diluted basis, and as a result of this and other factors, I/P was deemed to be the acquiring company for accounting purposes and the transaction was accounted for as a reverse acquisition in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Accordingly, the Company’s financial statements for periods prior to the M<font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">erger reflect the historical results of I/P</font>, and the Company’s financial statements for all periods from July 19, 2012 reflect the results of the combined company. Unless specifically noted otherwise, as used throughout these consolidated financial statements, the term “Company” refers to the combined company after the Merger, and the business of I/P before the Merger. The terms I/P and Vringo or Legal Parent refer to such entities’ standalone businesses prior to the Merger.</font><font style="FONT-SIZE: 10pt"></font></div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	vrng	Percentage Of Interest Owned Reverse Acquisition Transaction PercentageOfInterestOwnedReverseAcquisitionTransaction	0.6761	pure
CY2013Q3	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	88070	shares
CY2012Q3	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	353232	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	124506	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	117744	shares
	vrng	Incremental Common Shares Attributable To Share Based Payment Arrangements Basic IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsBasic	109930	shares
	vrng	Incremental Net Income Loss Available To Derivative Warrants IncrementalNetIncomeLossAvailableToDerivativeWarrants	7240000	USD
	vrng	Incremental Net Income Loss Available To Derivative Warrants IncrementalNetIncomeLossAvailableToDerivativeWarrants	3387000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt; COLOR: black">(d) Use of estimates</font></i></strong><font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">  </font> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include valuation of assets acquired and liabilities assumed as part of the Merger, useful lives of the Company’s tangible and intangible assets, valuation of its October 2012 Warrants and derivative warrants, valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties and other contingencies.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	83450697	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	48437587	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	82757899	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	25493415	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	46229656	shares
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11318000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10364000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-33517000	USD
CY2013Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28512182	shares
CY2012Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25240504	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30972531	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25240504	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27798277	shares
CY2013Q3	vrng	Weighted Average Number Of Derivative Warrants Outstanding WeightedAverageNumberOfDerivativeWarrantsOutstanding	2563090	shares
CY2012Q3	vrng	Weighted Average Number Of Derivative Warrants Outstanding WeightedAverageNumberOfDerivativeWarrantsOutstanding	9436281	shares
	vrng	Weighted Average Number Of Derivative Warrants Outstanding WeightedAverageNumberOfDerivativeWarrantsOutstanding	89677	shares
	vrng	Weighted Average Number Of Derivative Warrants Outstanding WeightedAverageNumberOfDerivativeWarrantsOutstanding	9436281	shares
	vrng	Weighted Average Number Of Derivative Warrants Outstanding WeightedAverageNumberOfDerivativeWarrantsOutstanding	1460477	shares
CY2013Q3	vrng	Incremental Net Income Loss Available To Derivative Warrants IncrementalNetIncomeLossAvailableToDerivativeWarrants	758000	USD
CY2012Q3	vrng	Incremental Net Income Loss Available To Derivative Warrants IncrementalNetIncomeLossAvailableToDerivativeWarrants	7240000	USD
	vrng	Incremental Net Income Loss Available To Derivative Warrants IncrementalNetIncomeLossAvailableToDerivativeWarrants	53000	USD
CY2012Q3	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	22000000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36927000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36827000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6567000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2783000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30360000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34044000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1257000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5009000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5009000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4618000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	14467000	USD
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	vrng	Fair Value Inputs Probability Of Achieving Target FairValueInputsProbabilityOfAchievingTarget	0.05	pure
	vrng	Fair Value Assumptions Timing Of Down Round Triggering Event FairValueAssumptionsTimingOfDownRoundTriggeringEvent	December 2013
CY2013Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	4126000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	7612000	USD
CY2011Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7612000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Recorded In Connection With Merger FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRecordedInConnectionWithMerger	21954000	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4126000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Derivative Warrants Issued By Legal Parent FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityDerivativeWarrantsIssuedByLegalParent	3162000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	156000	USD
CY2012	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants	10657000	USD
	vrng	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants	790000	USD
CY2012	vrng	Fair Value Measurement Adjusted In Earnings FairValueMeasurementAdjustedInEarnings	-7003000	USD
	vrng	Fair Value Measurement Adjusted In Earnings FairValueMeasurementAdjustedInEarnings	-411000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	15000	USD
	vrng	Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval Fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityderivativewarrantsremoval	-2300000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2012	vrng	Class Of Warrant Or Right Exercise ClassOfWarrantOrRightExercise	250000000	shares
CY2012Q4	vrng	Expected Term Of Warrants ExpectedTermOfWarrants	P2Y7M28D
CY2013Q3	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill	65965000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	78816000	USD
CY2011Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	8768014	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16972977	shares
CY2012	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	890192	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	265000	shares
CY2012	vrng	Legal Parents Shares Of Common Stock Recorded Upon Merger LegalParentsSharesOfCommonStockRecordedUponMerger	15206118	shares
CY2012	vrng	Waarrants Issued And Exercised WaarrantsIssuedAndExercised	754400	shares
CY2012	vrng	Waarrants Issued And Exercised Before Merger WaarrantsIssuedAndExercisedBeforeMerger	6832150	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	726346	shares
CY2012Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	20136445	shares
	vrng	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	421493	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1810005	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9149105	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3223333	shares
	vrng	Share Based Compensation Arrangement Award Options Exercised ShareBasedCompensationArrangementAwardOptionsExercised	717735	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	417821	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	954868	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10282014	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5099098	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.22
	vrng	Share Based Compensation Arrangement Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue	2.96
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.44
	vrng	Share Based Compensation Arrangement Award Equity Instruments Other Than Options Expired At Merger Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementAwardEquityInstrumentsOtherThanOptionsExpiredAtMergerWeightedAverageGrantDateFairValue	1.58
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.53
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18863261	shares
CY2013Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18441768	shares
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	175000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	62000	USD
CY2013Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	68000	USD
CY2012Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	40000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	56000	USD
CY2013Q3	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Derivative Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDerivativeLiability	3162000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	3162000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	179000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	104000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	306000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	339000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	75654000	USD
CY2013Q3	vrng	Business Combination Consideration Transferred Stock Options Granted BusinessCombinationConsiderationTransferredStockOptionsGranted	7364000	USD
CY2013Q3	vrng	Business Combination Consideration Transferred Warrants Granted BusinessCombinationConsiderationTransferredWarrantsGranted	10079000	USD
CY2013Q3	vrng	Business Combination Consideration Transferred Equity Interests Issued And Penny Options Granted BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndPennyOptionsGranted	58211000	USD
CY2013Q3	vrng	Business Acquisitions Cost Of Acquired Entity Purchase Price BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice	75654000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2285000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	487000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	281000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-73855000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-18298000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-6632000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	10133000	USD
CY2012Q4	vrng	Guarantee Placed For Contingent Loss In Litigation GuaranteePlacedForContingentLossInLitigation	2900000	USD
CY2013Q2	vrng	Guarantee Placed For Contingent Loss In Litigation GuaranteePlacedForContingentLossInLitigation	2900000	USD
CY2012Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	6673	shares
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q3	vrng	Business Acquisition Purchases Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasesPriceAllocationAssetsAcquiredLiabilitiesAssumedNet	75654000	USD
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	463000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	2586000	USD
CY2013Q3	vrng	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Deposit BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDeposit	8000	USD
CY2013Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	124000	USD

Files In Submission

Name	View Source	Status
0001144204-13-059609-index-headers.html	Edgar Link	pending
0001144204-13-059609-index.html	Edgar Link	pending
0001144204-13-059609.txt	Edgar Link	pending
0001144204-13-059609-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v358065_10q.htm	Edgar Link	pending
v358065_ex31-1.htm	Edgar Link	pending
v358065_ex31-2.htm	Edgar Link	pending
v358065_ex32-1.htm	Edgar Link	pending
v358065_ex32-2.htm	Edgar Link	pending
vrng-20130930.xml	Edgar Link	completed
vrng-20130930.xsd	Edgar Link	pending
vrng-20130930_cal.xml	Edgar Link	unprocessable
vrng-20130930_def.xml	Edgar Link	unprocessable
vrng-20130930_lab.xml	Edgar Link	unprocessable
vrng-20130930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XWEL
XWELL Inc Stock $xwel

2013 Q4 Form 10-Q Financial Statement

#000114420413059609 Filed on November 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL XWELL Inc Stock $xwel

2013 Q4 Form 10-Q Financial Statement

#000114420413059609 Filed on November 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XWEL
XWELL Inc Stock $xwel